# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1666333 | B | Inhibition of methicillin-susceptible Staphylococcus aureus ATCC 29213 PBP 1 | Staphylococcus aureus | 1 | ALA1649541 | single protein format | Scientific Literature | |
2. | ALA1667056 | B | Inhibition of methicillin-susceptible Staphylococcus aureus ATCC 29213 PBP 2 | Staphylococcus aureus | 1 | ALA1649541 | single protein format | Scientific Literature | |
3. | ALA1667057 | B | Inhibition of methicillin-susceptible Staphylococcus aureus ATCC 29213 PBP 3 | Staphylococcus aureus | 1 | ALA1649541 | single protein format | Scientific Literature | |
4. | ALA1667058 | B | Inhibition of methicillin-susceptible Staphylococcus aureus ATCC 29213 PBP 4 | Staphylococcus aureus | 1 | ALA1649541 | single protein format | Scientific Literature | |
5. | ALA1667059 | B | Inhibition of methicillin-resistant Staphylococcus aureus OC 3726 PBP 2a | Staphylococcus aureus | 1 | ALA1649541 | single protein format | Scientific Literature | |
6. | ALA1667060 | F | Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 by M7-A7 dilution method | Staphylococcus aureus | 3 | ALA1649541 | organism-based format | Scientific Literature | |
7. | ALA1667061 | A | Steady state volume of distribution in human | Homo sapiens | 1 | ALA1649541 | organism-based format | Scientific Literature | |
8. | ALA1667062 | A | Plasma protein binding in human | Homo sapiens | 1 | ALA1649541 | cell-free format | Scientific Literature | |
9. | ALA1667063 | F | Antimicrobial activity against methicillin-resistant Staphylococcus aureus infected in patient with complicated skin and skin structure infection assessed as cure rate at 500 mg/kg, iv administered every 12 hrs | Staphylococcus aureus | 1 | ALA1649541 | organism-based format | Scientific Literature | |
10. | ALA1667064 | F | Antimicrobial activity against methicillin-resistant Staphylococcus aureus infected in patient with complicated skin and skin structure infection assessed as cure rate at 1 g/kg, iv administered every 12 hrs | Staphylococcus aureus | 1 | ALA1649541 | organism-based format | Scientific Literature |